|
Volumn 29, Issue 1, 2002, Pages 36-40
|
Prognostic factors in mesothelioma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
EPIRUBICIN;
ETOPOSIDE;
MITOXANTRONE;
PACLITAXEL;
AGE;
CLINICAL TRIAL;
HUMAN;
MALIGNANT MESOTHELIOMA;
MESOTHELIOMA;
PATHOGENESIS;
PATIENT SELECTION;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
SCORING SYSTEM;
WEIGHT REDUCTION;
|
EID: 0036179622
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: 10.1053/sonc.2002.30299 Document Type: Article |
Times cited : (39)
|
References (26)
|